Northland Securities Lifts Earnings Estimates for Transcat

Key Points

• Northland Securities raised its Q3 2027 EPS estimate for Transcat to $0.22 from $0.20 and forecast FY2027 EPS of $2.00, while maintaining an “Outperform” rating and $95 price target.
• Transcat’s latest quarter beat expectations, with EPS of $0.64 versus $0.45 and revenue of $97.1 million versus $92.5 million. Management also lifted its FY2027 organic service revenue growth outlook to the low double digits.
• Analyst views are mixed: Oppenheimer upgraded the stock and set a $115 target, while MarketBeat’s consensus rating is “Hold” with a $108.33 target. Shares were reported down 7.2% after a sharp post-earnings rally.

Transcat, Inc. (NASDAQ:TRNS - Free Report) - Analysts at Northland Securities raised their Q3 2027 earnings estimates for Transcat in a research report issued on Wednesday, November 4th. Northland Securities analyst T. Jackson now expects that the scientific and technical instruments company will post earnings per share of $0.22 for the quarter, up from their prior forecast of $0.20. Northland Securities currently has an "Outperform" rating and a $95.00 target price on the stock. The consensus estimate for Transcat's current full-year earnings is $1.84 per share. Northland Securities also issued estimates for Transcat's Q4 2027 earnings at $0.64 EPS, FY2027 earnings at $2.00 EPS, FY2028 earnings at $2.18 EPS, FY2029 earnings at $2.65 EPS, FY2030 earnings at $3.10 EPS and FY2031 earnings at $3.69 EPS.

Transcat (NASDAQ:TRNS - Get Free Report) last posted its quarterly earnings data on Tuesday, November 3rd. The scientific and technical instruments company reported $0.64 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.45 by $0.19. The business had revenue of $97.09 million during the quarter, compared to the consensus estimate of $92.46 million. Transcat had a net margin of 1.26% and a return on equity of 6.14%.

A number of other equities research analysts have also recently issued reports on the stock. Oppenheimer upgraded shares of Transcat from a "market perform" rating to an "outperform" rating and set a $115.00 price target for the company in a report on Wednesday. Weiss Ratings reissued a "sell (d+)" rating on shares of Transcat in a research report on Tuesday, August 25th. Finally, CJS Securities started coverage on Transcat in a research report on Tuesday, October 27th. They set an "outperform" rating and a $115.00 price objective for the company. Three equities research analysts have rated the stock with a Buy rating, one has issued a Hold rating and one has assigned a Sell rating to the company's stock. According to data from MarketBeat, Transcat has an average rating of "Hold" and a consensus target price of $108.33.

Transcat Stock Down 7.2%

Transcat stock opened at $100.38 on Friday. The firm has a market cap of $943.57 million, a price-to-earnings ratio of 209.13 and a beta of 0.61. The company has a debt-to-equity ratio of 0.38, a current ratio of 2.57 and a quick ratio of 2.11. Transcat has a fifty-two week low of $50.23 and a fifty-two week high of $110.47. The firm has a fifty day moving average price of $86.71 and a two-hundred day moving average price of $82.24.

Hedge Funds Weigh In On Transcat

Large investors have recently bought and sold shares of the stock. Integrated Wealth Concepts LLC bought a new stake in shares of Transcat in the 2nd quarter worth approximately $32,000. Persistent Asset Partners Ltd acquired a new stake in shares of Transcat during the 2nd quarter worth approximately $52,000. GAMMA Investing LLC increased its position in shares of Transcat by 133.6% during the third quarter. GAMMA Investing LLC now owns 1,030 shares of the scientific and technical instruments company's stock valued at $91,000 after purchasing an additional 589 shares during the period. Squarepoint Ops LLC increased its position in shares of Transcat by 9.0% during the second quarter. Squarepoint Ops LLC now owns 8,794 shares of the scientific and technical instruments company's stock valued at $816,000 after purchasing an additional 728 shares during the period. Finally, Corient Private Wealth LP increased its position in shares of Transcat by 9.1% during the second quarter. Corient Private Wealth LP now owns 9,509 shares of the scientific and technical instruments company's stock valued at $882,000 after purchasing an additional 791 shares during the period. 98.34% of the stock is currently owned by institutional investors and hedge funds.

Transcat News Summary

Here are the key news stories impacting Transcat this week:

• Positive Sentiment: Transcat beat earnings and revenue estimates, reporting $0.64 per share versus the $0.45 consensus and $97.1 million in revenue versus $92.5 million expected. Service momentum and acquisitions contributed to the above-consensus quarter. Why Transcat Is Up 20.8% And What's Next After Earnings Beat
• Positive Sentiment: Management raised its fiscal 2027 outlook for organic service revenue growth to the low double digits and is targeting at least 100 basis points of service gross-margin expansion in the second half. The company also reported double-digit organic service growth and significant service margin improvement. Transcat raises FY2027 service outlook
• Positive Sentiment: Oppenheimer upgraded TRNS from “market perform” to “outperform” and set a $115 price target, signaling improved analyst confidence after the results.
• Neutral Sentiment: Shares had surged about 20.8% and reached a record after the earnings release. The subsequent decline may reflect investors taking profits after that rapid move, rather than a negative development reported in these articles.
• Negative Sentiment: The sharp post-earnings rally may leave the stock vulnerable to volatility or further profit-taking; the supplied coverage does not identify a new company-specific negative catalyst.

Transcat Company Profile

Transcat, Inc NASDAQ: TRNS provides calibration, compliance, and measurement services for organizations that rely on accurate test and measurement equipment. The company supports customers in regulated industries, including life sciences, aerospace and defense, energy, manufacturing, and other industrial markets.

Its service offerings include laboratory and onsite calibration, repair, validation, and asset-management services. Transcat calibrates a broad range of equipment used to measure temperature, pressure, electrical and electronic properties, radio frequency signals, dimensional characteristics, and other technical parameters.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.